Kirkland Guides Health-Focused SPAC's $500M IPO Plans
A special purpose acquisition company co-founded by a former KKR dealmaker and a biotechnology executive said Tuesday it plans to raise roughly $500 million in an initial public offering steered by...To view the full article, register now.
Already a subscriber? Click here to view full article